Jaguar Health, Inc.
- JAGX
- NASDAQ
- Biotechnology
- Gastrointestinal Drugs
- Animal Health Pharmaceuticals
$3.52
Today −23.20%Quote Oct 16, 2026, 08:00 PM UTC
+28.36%over the last month
Max drawdown −89.8%From 1-month high −89.8%3 months −81.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$190,142.025
Approximate share count
Next earnings
Nov 12
Expected, not confirmed
Analyst target
$3.21
−8.9% from here
Floor
$3.50
0.7% below price
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about JAGXPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
Q2 2026 revenue $1.3M
- Mytesi$1.2M96.0%
- License$43,0003.4%
- Neonorm$7,0000.6%
Industry
Biotechnology
Employees
47